Cardiopulmonary risk has recently been proposed and is defined as: The risk of serious and/or cardiovascular events in ...

When estimating 4-year all-cause mortality risk, researchers again reported low performance with use of the GOLD COPD exacerbation history categories (AUROC, 0.55; sensitivity, 36.6%; specificity ...

Researchers recruited patients from the London COPD Exacerbation Cohort to examine how levels of SPMs, particularly RvD1, in the sputum of patients with COPD change over time during exacerbations ...

The study highlighted the significant benefits of long-term oxygen therapy in reducing total and hospitalized acute ...

The epidemiology of exacerbations of chronic obstructive pulmonary disease (COPD) is reviewed with particular reference to the definition, frequency, time course, natural history and seasonality, and ...

Dupilumab decreased exacerbations in those with COPD and T2 inflammation by 28.2% (baseline BODE score ≤4) to 34.4% (BODE score >4) over a 1-year period. Dupilumab was associated with a decrease in ...

are associated with a lower risk of chronic obstructive pulmonary disease (COPD) exacerbations in patients with Type 2 diabetes (T2D) and active COPD compared with dipeptidyl peptidase-4 inhibitors ...

This is attributed to increased systemic inflammation. The course of COPD is punctuated by exacerbations, which further increase systemic inflammation, but the risk of vascular events in the ...

The Acute Exacerbation and Respiratory InfectionS in COPD (AERIS) observational cohort study allows for a unique examination ... for subjects followed over 1 year for the primary study objective ...

is a common cause of death and disability, little is known about the effects of socioeconomic status (SES) and race–ethnicity on health outcomes. Methods The aim of this study is to determine the ...

Learn more about supplements for lung health, including vitamins, minerals, and herbs that support breathing, reduce ...